1 Galie, N. et al. 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. Rev Esp Cardiol (Engl Ed) 69, 177, doi:10.1016/j.rec.2016.01.002 (2016).
2 Lilienfeld, D. E. & Rubin, L. J. Mortality from primary pulmonary hypertension in the United States, 1979-1996. Chest 117, 796-800, doi:10.1378/chest.117.3.796 (2000).
3 Ghofrani, H. A. et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 136, 515-522, doi:10.7326/0003-4819-136-7-200204020-00008 (2002).
4 Hoeper, M. M. et al. Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension. Eur Respir J 24, 1007-1010, doi:10.1183/09031936.04.00051104 (2004).
5 Galie, N. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37, 67-119, doi:10.1093/eurheartj/ehv317 (2016).
6 Humbert, M. et al. Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era. Circulation 122, 156-163, doi:doi:10.1161/CIRCULATIONAHA.109.911818 (2010).
7 Wang, L. Y. et al. Long-Term Survival of Patients with Pulmonary Arterial Hypertension at a Single Center in Taiwan. Acta Cardiol Sin 33, 498-509 (2017).
8 Benza, R. L. et al. An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry. CHEST 142, 448-456, doi:10.1378/chest.11-1460 (2012).
9 Hoeper, M. M. et al. Risk assessment in pulmonary arterial hypertension. European Respiratory Journal 51, 1702606, doi:10.1183/13993003.02606-2017 (2018).
10 Raina, A. & Humbert, M. Risk assessment in pulmonary arterial hypertension. European Respiratory Review 25, 390-398, doi:10.1183/16000617.0077-2016 (2016).
11 Ho, Y. L., Lin, C., Lin, Y. H. & Lo, M. T. The prognostic value of non-linear analysis of heart rate variability in patients with congestive heart failure--a pilot study of multiscale entropy. PLoS One 6, e18699, doi:10.1371/journal.pone.0018699 (2011).
12 Ferrario, M. et al. Non-Linear Heart Rate Variability Indices in the Frequent Hemodialysis Network Trials of Chronic Hemodialysis Patients. Blood Purif 40, 99-108, doi:10.1159/000381665 (2015).
13 Tsai, C. H. et al. Heart Rhythm Complexity Impairment in Patients with Pulmonary Hypertension. Sci Rep 9, 10710, doi:10.1038/s41598-019-47144-1 (2019).
14 Makikallio, T. H. et al. Fractal analysis and time- and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol 87, 178-182 (2001).
15 Sitbon, O. & Simonneau, G. Optimal management of severe pulmonary arterial hypertension. Eur Respir Rev 20, 254-261, doi:10.1183/09059180.00007011 (2011).
16 Ling, Y. et al. Changing Demographics, Epidemiology, and Survival of Incident Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine 186, 790-796, doi:10.1164/rccm.201203-0383OC (2012).
17 Casolo, G., Balli, E., Taddei, T., Amuhasi, J. & Gori, C. Decreased spontaneous heart rate variability in congestive heart failure. Am J Cardiol 64, 1162-1167, doi:10.1016/0002-9149(89)90871-0 (1989).
18 Goncalves, H. et al. Analysis of heart rate variability in a rat model of induced pulmonary hypertension. Med Eng Phys 32, 746-752, doi:10.1016/j.medengphy.2010.04.018 (2010).
19 Huikuri, H. V. et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 19, 1979-1985 (1999).
20 Ciarka, A., Doan, V., Velez-Roa, S., Naeije, R. & van de Borne, P. Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Am J Respir Crit Care Med 181, 1269-1275, doi:10.1164/rccm.200912-1856OC (2010).
21 Velez-Roa, S. et al. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation 110, 1308-1312, doi:10.1161/01.CIR.0000140724.90898.D3 (2004).
22 Isobe-Sasaki, Y. et al. Sodium balance, circadian BP rhythm, heart rate variability, and intrarenal renin-angiotensin-aldosterone and dopaminergic systems in acute phase of ARB therapy. Physiol Rep 5, e13309, doi:10.14814/phy2.13309 (2017).
23 Saul, J. P. et al. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol 61, 1292-1299, doi:10.1016/0002-9149(88)91172-1 (1988).
24 Florea, V. G. & Cohn, J. N. The autonomic nervous system and heart failure. Circ Res 114, 1815-1826, doi:10.1161/CIRCRESAHA.114.302589 (2014).
25 Vaillancourt, M. et al. Autonomic nervous system involvement in pulmonary arterial hypertension. Respir Res 18, 201, doi:10.1186/s12931-017-0679-6 (2017).
26 Bienias, P. et al. Severity of arterial and chronic thromboembolic pulmonary hypertension is associated with impairment of heart rate turbulence. Ann Noninvasive Electrocardiol 20, 69-78, doi:10.1111/anec.12169 (2015).
27 Peng, C. K., Havlin, S., Stanley, H. E. & Goldberger, A. L. Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. Chaos 5, 82-87, doi:10.1063/1.166141 (1995).
28 Costa, M., Goldberger, A. L. & Peng, C. K. Multiscale entropy analysis of complex physiologic time series. Phys Rev Lett 89, 068102 (2002).
29 Costa, M., Goldberger, A. L. & Peng, C. K. Multiscale entropy analysis of biological signals. Phys Rev E Stat Nonlin Soft Matter Phys 71, 021906, doi:10.1103/PhysRevE.71.021906 (2005).
30 Tsai, C. H. et al. Heart Rhythm Complexity Predicts Long-Term Cardiovascular Outcomes in Peritoneal Dialysis Patients: A Prospective Cohort Study. J Am Heart Assoc 9, e013036, doi:10.1161/JAHA.119.013036 (2020).
31 Busa, M. A. & van Emmerik, R. E. A. Multiscale entropy: A tool for understanding the complexity of postural control. J Sport Health Sci 5, 44-51, doi:10.1016/j.jshs.2016.01.018 (2016).
32 Patel, V. N. et al. Association of Holter-Derived Heart Rate Variability Parameters With the Development of Congestive Heart Failure in the Cardiovascular Health Study. JACC Heart Fail 5, 423-431, doi:10.1016/j.jchf.2016.12.015 (2017).
33 Binkley, P. F. Promise of a New Role for Heart Rate Variability in the Clinical Management of Patients With Heart Failure. JACC Heart Fail 5, 432-434, doi:10.1016/j.jchf.2017.02.008 (2017).
34 Tsuji, H. et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 94, 2850-2855 (1996).
35 Chiu, H. C. et al. Serial heart rhythm complexity changes in patients with anterior wall ST segment elevation myocardial infarction. Sci Rep 7, 43507, doi:10.1038/srep43507 (2017).
36 Chiang, J. Y. et al. Detrended Fluctuation Analysis of Heart Rate Dynamics Is an Important Prognostic Factor in Patients with End-Stage Renal Disease Receiving Peritoneal Dialysis. PLoS One 11, e0147282, doi:10.1371/journal.pone.0147282 (2016).
37 Tsai, C. H. et al. The association between heart rhythm complexity and the severity of abdominal aorta calcification in peritoneal dialysis patients. Sci Rep 8, 15627, doi:10.1038/s41598-018-33789-x (2018).
38 Lin, Y.-H. et al. Reversible heart rhythm complexity impairment in patients with primary aldosteronism. Scientific Reports 5, 11249, doi:10.1038/srep11249 (2015).
39 Tang, S. C. et al. Complexity of heart rate variability predicts outcome in intensive care unit admitted patients with acute stroke. J Neurol Neurosurg Psychiatry 86, 95-100, doi:10.1136/jnnp-2014-308389 (2015).
40 Folino, A. F. et al. Ventricular arrhythmias and autonomic profile in patients with primary pulmonary hypertension. Lung 181, 321-328, doi:10.1007/s00408-003-1034-x (2003).
41 Witte, C. et al. Heart Rate Variability and Arrhythmic Burden in Pulmonary Hypertension. Adv Exp Med Biol 934, 9-22, doi:10.1007/5584_2016_18 (2016).
42 Bienias, P. et al. Severity of arterial and chronic thromboembolic pulmonary hypertension is associated with impairment of heart rate turbulence. Ann Noninvasive Electrocardiol 20, 69-78, doi:10.1111/anec.12169 (2015).
43 Bienias, P. et al. Functional class and type of pulmonary hypertension determinate severity of cardiac autonomic dysfunction assessed by heart rate variability and turbulence. Acta Cardiol 70, 286-296, doi:10.2143/AC.70.3.3080633 (2015).
44 Semen, K., Solovey, L., Karapinka, M. & Yelisyeyeva, O. Heart rate variability: Possible implications for management of pulmonary arterial hypertension patients. European Respiratory Journal 40, P970 (2012).
45 Andersen, M. Ø., Diederichsen, S. Z., Svendsen, J. H. & Carlsen, J. HEART RATE VARIABILITY AS ASSESSED WITH LONG-TERM CONTINUOUS CARDIAC MONITORING IN PULMONARY HYPERTENSION. Journal of the American College of Cardiology 75, 2088, doi:10.1016/s0735-1097(20)32715-7 (2020).
46 Humbert, M. Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology. Eur Respir Rev 19, 59-63, doi:10.1183/09059180.00007309 (2010).
47 Thenappan, T., Ormiston, M. L., Ryan, J. J. & Archer, S. L. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ 360, j5492, doi:10.1136/bmj.j5492 (2018).
48 Glanville, A. R., Burke, C. M., Theodore, J. & Robin, E. D. Primary pulmonary hypertension. Length of survival in patients referred for heart-lung transplantation. Chest 91, 675-681, doi:10.1378/chest.91.5.675 (1987).
49 Montani, D. et al. Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre. Eur Respir Rev 18, 272-290, doi:10.1183/09059180.00005909 (2009).
50 Mitchell, C. et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. Journal of the American Society of Echocardiography 32, 1-64, doi:10.1016/j.echo.2018.06.004 (2019).
51 Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93, 1043-1065 (1996).
52 Peng, C. K. et al. Fractal mechanisms and heart rate dynamics: Long-range correlations and their breakdown with disease. Journal of Electrocardiology 28, 59-65, doi:https://doi.org/10.1016/S0022-0736(95)80017-4 (1995).
53 Steyerberg, E. W. et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21, 128-138, doi:10.1097/EDE.0b013e3181c30fb2 (2010).
54 Kerr, K. F. et al. Net reclassification indices for evaluating risk prediction instruments: a critical review. Epidemiology 25, 114-121, doi:10.1097/EDE.0000000000000018 (2014).